Dr Mervat Mohamed Naguib Gharib Hussin

Degree

• M.B.B.Ch
• MSc.
• MD
• PHD
• Royal College of Physicians of Edinburgh

Designation and Specialty

Consultant Endocrinology

Work experience

• Diabetes and Endocrinology and Internal Medicine Consultant
• 2004-2019: Kasr Al Ainy School of Medicine Cairo University, Egypt
• AL Wadi Hospital, Egypt
• Al Kateb Hospital, Egypt
• 2019-2021: ACDS, Abu Dhabi
• 2021-2023: Aster Medical Centre, Abu Dhabi
• SEHA (AHS)`

Education and Training

• 2002: M.B.B.Ch – Cairo University, Egypt -Excellent with honors
• 2008: MSc. (Internal Medicine) – Cairo University, Egypt
• 2012: MD (Internal Medicine) – Cairo University, Egypt
• 2014: Royal College of Physicians of Edinburgh – Diabetes and Endocrinology Specialty Certificate
• 2016: MSc. (Diabetes, Endocrinology, Metabolism and Clinical Nutrition) – Cairo University, Egypt
• 2004-2007: Residency training at Kasr Al Ainy School of Medicine, Cairo University, Egypt
• 2007-2008: Residency Training at New Kasr Al Ainy School of Medicine, Cairo University, Egypt
• 2009-2010: Professional Development and Training in Emergency Medicine at Ronald Reagan Institute, George Washington University, Washington DC, USA

Membership

• 2010: Best Assistant Lecturer, Faculty of Medicine, Cairo University, Egypt
• 2018: Best presentation at DIA Egypt
• 2019: International publication award from Cairo University, Egypt

Awards and recognitions

• 2010: Best Assistant Lecturer, Faculty of Medicine at Cairo University, Egypt
• 2018: Best Presentation at DIA Egypt
• 2019: International Publication Award from Cairo University, Egypt

Researsch paper

Invited as speaker in seminars and conferences
2016: The 13th Annual Conference (Diabetes: Gut and Liver)
2016: The 8th National Egyptian Diabetes Congress (Egyptian Society of Diabetes and Lipidology)
2016-2017: The 3rd Annual Clinical Lipidology Forum (Egyptian Society of Diabetes and Lipidology
2018: Poster Presentations ECE Conference
2019: Military Conference – Obesity
2019: El Azhar Medical Conference – Obesity
2019: Vascular Calcification Group Annual Meeting
2021-2022: ACCE – Poster Presentations (UAE)

List of publication
Circulating MicroRNA-30a, Beclin1 and Their Association with Different Variables in Females with Metabolically Healthy /Unhealthy Obesity(2023)
Factors associated with glycemic control and diabetes complications in a group of Saudi patients with type 2 diabetes(2023)
Assessment of early macular microangiopathy in subjects with prediabetes using optical coherence tomography angiography and fundus photography(2023)
Long non-coding RNA maternally expressed gene 3, miR-125a-5p, CXCL13, and NF-kB in patients with immune thrombocytopenia(2023)
Does Serum Osteocalcin Level Affect Carotid Atherosclerosis in Post-Menopausal Diabetic Females? A Case-Control Study(2022)
Elevated Serum Cyclophilin D Level is Associated with Nonalcoholic Fatty Liver Disease and Higher Fibrosis Scores in Patients with Diabetes Mellitus(2021)
Beclin1 circulating level as predictor of carotid intima-media thickness in patients with type 2 diabetes mellitus(2021)
The Effect of Bariatric Surgery versus Intensive Medical Care on Prevention of Microalbuminuria in Patients with Type 2 Diabetes: 3 Year Experience of a Prospective Study (2021)
Single Nucleotide Polymorphisms in CDKAL1 Gene are Not Associated with Risk of Type 2 Diabetes Mellitus in a Group of Egyptian Population (2020)
Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis(2019)
A significant upsurge of body mass index in patients with chronic hepatitis C successfully treated with direct-acting antiviral regimens (2019)
Irisin level in type 2 diabetic patients and its relation to glycemic control and diabetic complications (2019)
Serum level of the autophagy biomarker Beclin-1 in patients with diabetic kidney disease (2018)
Managing diabetes and liver disease association (2018)
Is 25- Hydroxy Vitamin D a Real Index of Vitamin D Status in Pre-Dialysis Chronic Kidney Disease Patients(2018)
Negative Association between Serum 25 Hydroxy Vitamin D and Serum Uric Acid among Stage 3-5 Chronic Kidney Disease Patients (2018)
Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients(2018)
S.TCF7L2 Gene Polymorphisms and Susceptibility to Type 2 Diabetes Mellitus, a Pilot Study(2018) o Endocrine Abstracts (2018)
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations(2018)
Spleen size in patients with metabolic syndrome and its relation to anthropometric, metabolic and (2018)
Urinary connective tissue growth factor level in relation to nephropathy and retinopathy in patients with type 2 diabetes(2018)
Prognostic value of Hepatocyte growth factor in dialysis chronic renal failure patients with heart failure. ( 2017)
Adiponectin level in Egyptian type 2 diabetic patients and its relation to glycemic control and lipid profile. (2017)
Prognostic value of the biomarker copeptin in critically ill patients with sepsis(2016)
Variceal index: Scoring system for prediction of esophageal varices using non-invasive parameter(2016)
“Outcome prediction for critically ill Egyptian cirrhotic patients in liver intensive care unit”, 17th Conference of European Society of Organ Transplantation (ESOT), Brussels, 13 Sep 2015.
Comparison of different scoring systems in predicting short-term mortality after liver transplantation.Transplant (2015)
Endothelial growth factor before and after locoregional treatment and its relation to treatment response in hepatocelluar carcinoma patients(2015)
Viral Load and Genotype Matter in Hepatitis C Virus Related Heart Disease in Cirrhotic Patients. Journal of ( 2012)

Specialty Areas

• Eg: Hypertension
• Diabetes
• Thyroid disorders
• Infectious disease
• Chronic respiratory diseases
• Rheumatologic disorders
• Vitamin and mineral deficiencies

Languages Spoken

• English
• Arabic